APA (7th ed.) Citation

PH, K., CY, T., CH, C., KC, K., JY, H., MC, L., . . . CC, S. (2024). Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study. Biomedicines, 12(10), . https://doi.org/10.3390/biomedicines12102348

Chicago Style (17th ed.) Citation

PH, Kuo, Tu CY, Chen CH, Kao KC, Hsu JY, Lin MC, Chong IW, and Sheu CC. "Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study." Biomedicines 12, no. 10 (2024). https://doi.org/10.3390/biomedicines12102348.

MLA (9th ed.) Citation

PH, Kuo, et al. "Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study." Biomedicines, vol. 12, no. 10, 2024, https://doi.org/10.3390/biomedicines12102348.